InMed Conferences and Events
Upcoming Events
Past Events
Date: January 25, 2024
Time: 1:00pm ET
InMed CEO Eric A. Adams will join Water Tower Research in this Fireside Chat.
Date: January 25, 2024
Time: 1:00pm ET
Interested parties can register for the event here. Replays of the webcast will also be available after the event.
In this fireside chat, CEO Eric A. Adams will provide an update on our pharmaceutical programs and upcoming milestones. This event is open access for all investors. Topics will include:
- An overview of InMed’s pharmaceutical pipeline in Alzheimer’s and Age-related Macular Degeneration (“AMD”)
- A discussion of upcoming 2024 milestones in both InMed’s pharmaceutical drug development and in BayMedica’s health and wellness initiatives
- An overview of cannabinoids and their possible role in the treatment of Alzheimer’s
Date: January 30-February 1, 2024
InMed Pharmaceuticals will be attending The Microcap Conference 2024.
Dates: January 30- February 1, 2024
Location: Atlantic City, New Jersey
InMed CEO Eric A. Adams will present at the conference. More details will be shared on this events page.
More about the conference: https://themicrocapconference.com/
Date: November 7, 2023
Time: 4:08pm ET
InMed’s abstract describing the Phase 2 clinical study of investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of symptoms in patients with epidermolysis bullosa (“EB”), a rare genetic skin disease, has been accepted as an oral presentation at the 12th World Congress on Itch (WCI), being held in Miami on November 5-7, 2023.
Presentation details are below:
Abstract Title: INM-755 cannabinol cream demonstrates anti-itch activity in patients with epidermolysis bullosa
Presenting Author: Alexandra Mancini, Senior Vice President, Clinical and Regulatory Affairs, InMed Pharmaceutical Inc.
Session: Hot Topics
Date/Time: Tuesday, November 7 at 4:08 PM ET
Check our INM-755 for Epidermolysis Bullosa webpage for a copy of the poster, which will be available following the presentation.
Date: Sept. 27-28, 2023
Time: 11:40am CT
InMed’s subsidiary, BayMedica, will be participating at the upcoming Benzinga Cannabis Capital Conference September 27-28th in Chicago, IL.
Jerry Griffin, VP of Sales and Marketing at BayMedica, will be joining a panel discussion “Transforming the CPG Landscape: Why Rare Cannabinoids Ingredients are the Next Big Thing.”
Panel Discussion takes place Thursday, September 28 at 11:40am CT
Learn more about the speakers here.
Date: Sept. 11-13, 2023
Time: 7:00am
InMed will be participating in the H.C. Wainwright 25th Annual Global Investment Conference in New York City from September 11-13, 2023. CEO Eric A. Adams will present at the conference.
On-demand presentation available here. Presentation will be accessible for 90 days.
InMed’s management team will be available for onsite and virtual one-on-one meetings with registered investors during the conference. To request 1-on-1 meetings with the Company, please contact your H.C Wainwright institutional representative.
Date: June 1, 2023
Time: 11:30am ET
Eric A. Adams, CEO of InMed, will present a corporate overview followed by a Q&A session. Management will be available for virtual one-on-one meetings for qualified investors. The conference is complimentary to qualified investors. Please register through Investor Summit.
Date: May 31, 2023
Time: 12:00pm ET
Eric A. Adams, CEO of InMed, and Jerry Griffin, VP, Sales and Marketing of BayMedica, will co-host a presentation event titled, “Addressing The Increasing Demand For Rare Cannabinoids”.
Management will be available for a 5-10 minute Q&A session at the end of the presentation. Please send your questions for management to Tribe’s email: [email protected].
Watch the webinar recording here.
Date: May 23, 2023
Time: 1:00pm ET
InMed’s CEO, Eric A. Adams, will join Robert Sassoon of Water Tower Research for a Fireside Chat.
Join the meeting where they’ll discuss:
- InMed’s rare cannabinoid pharmaceutical programs in Epidermolysis Bullosa, Glaucoma and Neurodegenerative diseases
- Bioidentical rare cannabinoid sales by BayMedica, InMed’s subsidiary
- Upcoming catalysts
Date: March 9, 2023
Time: 11:00am ET
VirtualInvestorConferences.com – Life Sciences Investor Forum
InMed’s CEO, Mr Eric A. Adams, will perform a presentation followed by a questions and answers session. Management will be available for virtual one-on-one meetings with institutional and individual investors from March 9 – March 14.
Registration: https://bit.ly/3IoXpvP
Learn more about the event at www.virtualinvestorconferences.com
Date: March 8, 2023
Time: 12:30pm ET
Emerging Growth Conference
InMed’s CEO, Mr. Eric A. Adams, will perform a presentation followed by a questions and answers session. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel.
Watch the presentation here on demand